IFP Advisors, Inc - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 221 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 12.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$3
-100.0%
18
-80.6%
0.00%
Q3 2022$6,000
-14.3%
93
-48.0%
0.00%
Q2 2022$7,0000.0%1790.0%0.00%
Q1 2022$7,000
-75.0%
179
-87.3%
0.00%
-100.0%
Q4 2018$28,000
+3.7%
1,4100.0%0.00%
+100.0%
Q3 2018$27,000
+35.0%
1,410
+7.6%
0.00%0.0%
Q2 2018$20,000
+233.3%
1,310
+322.6%
0.00%
Q1 2018$6,0000.0%3100.0%0.00%
Q4 2017$6,000
-78.6%
310
-80.1%
0.00%
-100.0%
Q3 2017$28,0001,5600.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$4,884,3754.79%
SHAKER INVESTMENTS LLC/OH 82,253$3,084,4881.72%
Mesirow Institutional Investment Management, Inc. 325,669$12,212,5881.33%
Portolan Capital Management 340,593$12,772,2381.22%
OBERWEIS ASSET MANAGEMENT INC/ 178,200$6,682,5001.04%
Granite Investment Partners, LLC 536,821$20,130,7880.84%
Capital Impact Advisors, LLC 15,304$573,9000.70%
Hillsdale Investment Management Inc. 155,038$5,813,9260.50%
GLOBEFLEX CAPITAL L P 89,192$3,344,7000.41%
Jackson Creek Investment Advisors LLC 25,877$9700.41%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders